Adam Crystal sold $604K of TNGX stock

Adam Crystal, President, R&D of Tango Therapeutics, Inc. (TNGX), sold 27,000 shares of TNGX stock worth $604K, per an SEC Form 4 filed Sep 3, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 1, 2026, 2 days before it was made public.

TNGX has moved -3.8% since the trade date, from $22.35 to $21.50 (Nov 6, 2026 close).